Home › Research › Topics › intracerebroventricular
intracerebroventricular
4 studies tagged intracerebroventricular, dated 2014-11-06 to 2022-07-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels 2022-07-28
- Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation 2022-07-11
- Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin 2019-09-23
Studies
4 studies carry this tag.
Date range
2014 to 2022
Top journals
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 1
- Journal of the neurological sciences 1
- Metabolic brain disease 1
- Scientific reports 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
DPP-4 inhibitors have been shown to reverse amyloid deposition in Alzheimer's disease (AD) patients with cognitive impairment.
-
STZ/I.C.V is an effective way to induce AD mice model, with not only AD-like neuropsychiatric behaviors, but also typic AD-like neuropathological features including neurofibrillary tangles, deposit of β-amyloid (Aβ), neuroinflammation, and imbalanced synaptic plasticity.
-
Glucagon-like peptide 2 (GLP-2) is derived from the proglucagon gene expressed in the intestines, pancreas and brain.
-
Recent attention is given to the influence of dietary supplementation on health and mental well-being.